T2 Biosystems, Inc. (TTOO)
TTOO moved a median of -0.92% 30 minutes after news, and -0.83% by the close. How TTOO actually reacts to news — the realized, point-in-time move the market made, measured across 174 labeled events over the last three years with zero look-ahead.
TTOO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.23% | 54% | 174 |
| 30-min | -0.92% | 40% | 174 |
| 60-min | -1.20% | 40% | 174 |
| to close | -0.83% | 41% | 174 |
| Middle 50% of TTOO reactions | -3.61% to +2.63% |
|---|---|
| Median reaction (30-min) | -0.92% |
| Measured reactions | 174 |
Half of all T2 Biosystems, Inc. news events land between -3.61% and +2.63% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when TTOO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TTOO's baseline. Nothing else.
Recent TTOO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K T2 Biosystems, Inc. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | +3.42% | +2.56% | |
| Form NT 10-K T2 Biosystems, Inc. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -10.24% | |
| Form 8-K T2 Biosystems, Inc. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | -1.16% | +7.19% | |
| Form 8-K T2 Biosystems, Inc. For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | -7.55% | +54.08% | |
| Form 8-K T2 Biosystems, Inc. For: Feb 10 | SEC filing · Form 8-K | SEC EDGAR | +13.64% | +21.82% | |
| Form DEF 14A T2 Biosystems, Inc. For: Mar 03 | SEC filing · Form DEF | SEC EDGAR | -0.04% | +4.28% | |
| Form 8-K T2 Biosystems, Inc. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | +4.43% | +2.97% | |
| Form PRE 14A T2 Biosystems, Inc. For: Mar 03 | SEC filing · Form PRE | SEC EDGAR | -1.39% | -7.19% | |
| Form 8-K T2 Biosystems, Inc. For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | -2.38% | -2.38% | |
| T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results | Press release | GlobeNewswire | -2.38% | -2.38% | |
| Form 8-K T2 Biosystems, Inc. For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | -2.38% | |
| T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor | Press release | GlobeNewswire | -1.00% | -2.78% | |
| T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally | Press release | GlobeNewswire | -4.87% | -7.88% | |
| T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. | Press release | GlobeNewswire | -5.13% | -7.44% | |
| Form 8-K T2 Biosystems, Inc. For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | -3.62% | -16.36% | |
| Form 8-K T2 Biosystems, Inc. For: Dec 09 | SEC filing · Form 8-K | SEC EDGAR | +5.52% | +3.59% | |
| T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens | Press release | GlobeNewswire | +5.52% | +3.59% | |
| Form ARS T2 Biosystems, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -3.74% | -6.42% | |
| Form DEF 14A T2 Biosystems, Inc. For: Dec 30 | SEC filing · Form DEF | SEC EDGAR | -3.74% | -6.42% | |
| Form 8-K T2 Biosystems, Inc. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +3.77% | +7.58% | |
| Form 10-Q T2 Biosystems, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.19% | -0.76% | |
| T2 Biosystems Announces Third Quarter 2024 Financial Results | Press release | GlobeNewswire | -2.16% | +1.22% | |
| Form 8-K T2 Biosystems, Inc. For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | -1.58% | -17.27% | |
| Form PRE 14A T2 Biosystems, Inc. For: Dec 30 | SEC filing · Form PRE | SEC EDGAR | -0.21% | -0.45% | |
| T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 | Press release | GlobeNewswire | +2.58% | +0.44% | |
| Form 8-K T2 Biosystems, Inc. For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.55% | |
| T2 Biosystems to Host Business Update Call on October 10, 2024 | Press release | GlobeNewswire | -0.63% | +1.25% | |
| T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform | Press release | GlobeNewswire | -3.05% | -5.42% | |
| Form 8-K T2 Biosystems, Inc. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +1.94% | -9.44% | |
| T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens | Press release | GlobeNewswire | +1.94% | -9.44% | |
| T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results | Press release | GlobeNewswire | +1.94% | -9.44% | |
| T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture | Press release | GlobeNewswire | +0.91% | -6.79% | |
| Form 8-K T2 Biosystems, Inc. For: Sep 20 | SEC filing · Form 8-K | SEC EDGAR | +0.45% | -0.91% | |
| T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union | Press release | GlobeNewswire | +0.45% | -0.91% | |
| Form 8-K T2 Biosystems, Inc. For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | -3.42% | -12.17% | |
| T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients | Press release | GlobeNewswire | -3.42% | -12.17% | |
| Form 8-K T2 Biosystems, Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -1.67% | -10.67% | |
| T2 Biosystems Provides Updates on its New Product Development Pipeline Progress | Press release | GlobeNewswire | -1.67% | -10.67% | |
| T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference | Press release | GlobeNewswire | +0.00% | -10.40% | |
| Form 10-Q T2 Biosystems, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +6.11% | -1.02% | |
| T2 Biosystems to Attend Upcoming Investor Conferences | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form EFFECT T2 Biosystems, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +4.65% | +1.24% | |
| Form 8-K T2 Biosystems, Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +4.65% | +1.24% | |
| T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor | Press release | GlobeNewswire | +4.65% | +1.24% | |
| T2 Biosystems Announces Second Quarter 2024 Financial Results | Press release | GlobeNewswire | +4.65% | +1.24% | |
| T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024 | Press release | GlobeNewswire | +0.00% | -0.99% | |
| Form 8-K T2 Biosystems, Inc. For: Jul 19 | SEC filing · Form 8-K | SEC EDGAR | -4.07% | -5.56% | |
| Form S-3 T2 Biosystems, Inc. | SEC filing · Form S-3 | SEC EDGAR | -4.07% | -5.56% | |
| T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor | Press release | GlobeNewswire | +1.70% | -8.32% | |
| Form EFFECT T2 Biosystems, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -1.54% | +1.98% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TTOO section they belong to.
Where else TTOO is measured.
TTOO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (EDAP) | 174 | 0.00% | 45% |
| EVIO INC (EVIO) | 174 | 0.00% | 43% |
| EARTH SCIENCE TECH INC (ETST) | 173 | 0.00% | 33% |
| Exicure, Inc. (XCUR) | 173 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is T2 Biosystems, Inc.'s median reaction calculated?
Every labeled TTOO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 174 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 40% of TTOO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TTOO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.